Kromek Group PLC First US DHS Contract for Biosecurity for $5.9m (3787R)
October 26 2023 - 2:00AM
UK Regulatory
TIDMKMK
RNS Number : 3787R
Kromek Group PLC
26 October 2023
26 October 2023
Kromek Group plc
("Kromek" or the "Group")
First US Department of Homeland Security Contract for
Biosecurity
Award of $5.9m contract from US Government
Kromek Group plc (AIM: KMK) , a leading developer of radiation
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments, is pleased to announce that it has been
awarded a $5.9m contract from the US Department of Homeland
Security ("DHS") Countering Weapons of Mass Destruction ("CWMD")
Office for the research and development of technologies focusing on
an agent agnostic bio-detection system. The contract has been
awarded under a four-year programme, which commences immediately,
and the Group expects to receive $874k during the first year base
period.
Arnab Basu, CEO of Kromek Group, said: "We are pleased to have
been awarded this new contract for the research and development of
agent agnostic biosecurity technologies, which will build on our
existing expertise and technology in the field of automated
bio-detection solutions. It is our first biosecurity contract from
the Department of Homeland Security and underscores our belief that
there are significant market opportunities in this area, as our
technologies align well with government biosecurity strategies.
"This programme directly addresses a CWMD Office priority
focused on the detection, classification and identification of
bioterrorism attacks. Biological threats are an increasing priority
for governments, particularly in light of the pandemic. The output
of the programme is aimed at providing increased capability to
detect and identify biological threats in response to the
operational needs of the Department of Homeland Security and will
be an important step in making the world safer from the threat of
bioterrorism and other biological threats."
For further information, please contact:
Kromek Group plc
Arnab Basu, CEO
Paul Farquhar, CFO +44 (0)1740 626 060
Cavendish Capital Markets Limited (Nominated
Adviser and Broker)
Geoff Nash/Giles Balleny/Seamus Fricker -
Corporate Finance
Tim Redfern/Charlotte Sutcliffe - ECM
Michael Johnson/Tamar Cranford-Smith - Sales +44 (0)20 7220 0500
Gracechurch Group (Financial PR)
Harry Chathli/Claire Norbury/Henry Gamble +44 (0)20 4582 3500
Kromek Group plc
Kromek Group plc is a leading developer of radiation detection
and bio-detection technology solutions for the advanced imaging and
CBRN detection segments. Headquartered in County Durham, UK, Kromek
has manufacturing operations in the UK and US, delivering on the
vision of enhancing the quality of life through innovative
detection technology solutions.
The advanced imaging segment comprises the medical (including CT
and SPECT), security and industrial markets. Kromek provides its
OEM customers with detector components, based on its core cadmium
zinc telluride (CZT) platform, to enable better detection of
diseases such as cancer and Alzheimer's, contamination in
industrial manufacture and explosives in aviation settings.
In CBRN detection, the Group provides nuclear radiation
detection solutions to the global homeland defence and security
market. Kromek's compact, handheld, high-performance radiation
detectors, based on advanced scintillation and solid-state readout
technology, are primarily used to protect critical infrastructure,
events, personnel and urban environments from the threat of 'dirty
bombs'.
The Group is also developing bio-security solutions in the CBRN
detection segment. These consist of fully automated and autonomous
systems to detect a wide range of airborne pathogens.
Kromek is listed on AIM, a market of the London Stock Exchange,
under the trading symbol 'KMK'.
Acknowledgement of Sponsorship : This work is supported under
the U.S. Department of Homeland Security, Countering Weapons of
Mass Destruction Office, competitively award contract
70RWMD23C00000025. This support does not constitute an express or
implied endorsement on the part of the Government.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
MSCFEWSDMEDSESS
(END) Dow Jones Newswires
October 26, 2023 02:00 ET (06:00 GMT)
Kromek (LSE:KMK)
Historical Stock Chart
From Dec 2024 to Jan 2025
Kromek (LSE:KMK)
Historical Stock Chart
From Jan 2024 to Jan 2025
